tiprankstipranks
Trending News
More News >
Wakamoto Pharmaceutical Co., Ltd. (JP:4512)
:4512
Japanese Market

Wakamoto Pharmaceutical Co., Ltd. (4512) Financial Statements

Compare
0 Followers

Wakamoto Pharmaceutical Co., Ltd. Financial Overview

Wakamoto Pharmaceutical Co., Ltd.'s market cap is currently ¥10.55B. The company's EPS TTM is ¥2.4; its P/E ratio is 163.73; and it has a dividend yield of 0.99%. Wakamoto Pharmaceutical Co., Ltd. is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue¥ 7.74B¥ 8.66B¥ 8.38B¥ 8.89B¥ 10.92B
Gross Profit¥ 3.54B¥ 4.11B¥ 4.36B¥ 4.49B¥ 6.19B
Operating Income¥ -195.51M¥ 141.47M¥ -13.39M¥ -754.95M¥ -996.28M
EBITDA¥ 504.84M¥ 575.81M¥ 755.52M¥ -218.12M¥ -442.18M
Net Income¥ 108.96M¥ 138.26M¥ 238.54M¥ -601.86M¥ -1.66B
Balance Sheet
Cash & Short-Term Investments¥ 3.66B¥ 3.88B¥ 3.23B¥ 2.84B¥ 2.88B
Total Assets¥ 15.42B¥ 15.71B¥ 14.95B¥ 14.57B¥ 15.98B
Total Debt¥ 130.73M¥ 137.79M¥ 129.14M¥ 171.20M¥ 165.44M
Net Debt¥ -3.53B¥ -3.74B¥ -3.10B¥ -2.67B¥ -2.72B
Total Liabilities¥ 3.39B¥ 3.80B¥ 3.47B¥ 3.19B¥ 4.04B
Stockholders' Equity¥ 12.03B¥ 11.91B¥ 11.48B¥ 11.39B¥ 11.95B
Cash Flow
Free Cash Flow¥ -663.02M¥ 420.76M¥ -28.97M¥ -318.82M¥ -362.32M
Operating Cash Flow¥ -107.34M¥ 631.92M¥ 339.17M¥ 163.44M¥ -155.06M
Investing Cash Flow¥ -2.35M¥ 17.13M¥ 50.57M¥ -199.51M¥ -178.71M
Financing Cash Flow¥ -104.99M¥ -1.61M¥ -1.62M¥ -3.83M¥ -44.37M
Currency in JPY

Wakamoto Pharmaceutical Co., Ltd. Earnings and Revenue History

Wakamoto Pharmaceutical Co., Ltd. Debt to Assets

Wakamoto Pharmaceutical Co., Ltd. Cash Flow

Wakamoto Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis